Robeco Institutional Asset Management’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$68.2M Buy
1,168,427
+256,841
+28% +$15.2M 0.08% 234
2026
Q2
$51.1M Sell
911,586
-33,008
-3% -$1.72M 0.06% 264
2026
Q1
$45.3M Sell
944,594
-4,878
-0.5% -$214K 0.06% 260
2025
Q4
$36.7M Sell
949,472
-299,147
-24% -$11.4M 0.05% 280
2025
Q3
$44.1M Buy
1,248,619
+474,459
+61% +$17.2M 0.06% 248
2025
Q2
$27.9M Buy
774,160
+147,112
+23% +$4.87M 0.05% 305
2025
Q1
$19.5M Buy
627,048
+78,287
+14% +$2.48M 0.04% 337
2024
Q4
$14M Buy
548,761
+43,926
+9% +$1.16M 0.03% 384
2024
Q3
$14.3M Buy
504,835
+165,440
+49% +$4.58M 0.03% 386
2024
Q2
$8.95M Buy
339,395
+264,900
+356% +$7.34M 0.02% 442
2024
Q1
$2.26M Buy
74,495
+24,043
+48% +$709K ﹤0.01% 660
2023
Q4
$1.42M Buy
50,452
+42,256
+516% +$1.16M ﹤0.01% 748
2023
Q3
$222K Sell
8,196
-966
-11% -$28.7K ﹤0.01% 915
2023
Q2
$282K Sell
9,162
-14,399
-61% -$488K ﹤0.01% 912
2023
Q1
$849K Sell
23,561
-30,867
-57% -$1.14M ﹤0.01% 796
2022
Q4
$2.15M Sell
54,428
-51,675
-49% -$2.16M 0.01% 688
2022
Q3
$4.26M Buy
106,103
+30,450
+40% +$1.3M 0.01% 539
2022
Q2
$3.18M Buy
75,653
+43,027
+132% +$1.76M 0.01% 585
2022
Q1
$1.27M Buy
32,626
+27,347
+518% +$1.07M ﹤0.01% 687
2021
Q4
$210K Hold
5,279
– – ﹤0.01% 839
2021
Q3
$191K Hold
5,279
– – ﹤0.01% 852
2021
Q2
$216K Hold
5,279
– – ﹤0.01% 876
2021
Q1
$231K Buy
+5,279
New +$250K ﹤0.01% 860

Other funds holding RPRX

Robeco Institutional Asset Management's RPRX Position: Q3 2026 in Review

Robeco Institutional Asset Management increased its Royalty Pharma (RPRX) stake by 28% in Q3 2026, buying an estimated $15.2M and bringing the position to 1,168,427 shares worth $68.2M. The position accounts for 0.08% of the portfolio, ranked #234.

Robeco Institutional Asset Management first reported a position in RPRX in Q1 2021 and has held it in 23 quarters since. 705 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Robeco Institutional Asset Management held 1,168,427 shares of Royalty Pharma worth $68.2M as of Q3 2026.
  • Robeco Institutional Asset Management bought 256,841 Royalty Pharma shares in Q3 2026, an estimated $15.2M.
  • Royalty Pharma made up 0.08% of Robeco Institutional Asset Management's portfolio in Q3 2026, its #234 holding.
  • Robeco Institutional Asset Management first reported a position in Royalty Pharma in Q1 2021 and has held it in 23 quarters since.
  • 705 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q3 2026, filed 20 Oct 2026.